Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer

被引：0
|
作者：
Marta Wagner
Maciej Sobczyński
Monika Jasek
Konrad Pawełczyk
Irena Porębska
Piotr Kuśnierczyk
Andrzej Wiśniewski
机构：
[1] Polish Academy of Sciences,Laboratory of Genetics and Epigenetics of Human Diseases, Hirszfeld Institute of Immunology and Experimental Therapy
[2] Nencki Institute of Experimental Biology of the Polish Academy of Sciences,Laboratory of Molecular Neurobiology
[3] Department of Thoracic Surgery,Department of Pulmonology and Lung Oncology
[4] Lower Silesian Centre of Oncology,Laboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy
[5] Pulmonology and Haematology,undefined
[6] Wrocław Medical University,undefined
[7] Polish Academy of Sciences,undefined
来源：
BMC Cancer | / 23卷
关键词：
Non-small cell lung cancer; mRNA expression; rs26653; eQTL; Genetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer
    Wagner, Marta
    Sobczynski, Maciej
    Jasek, Monika
    Pawelczyk, Konrad
    Porebska, Irena
    Kusnierczyk, Piotr
    Wisniewski, Andrzej
    BMC CANCER, 2023, 23 (01)
  • [2] Down-regulation of ribosomal protein L22 in non-small cell lung cancer
    Mingxia Yang
    Haibo Sun
    Hong Wang
    Shijiang Zhang
    Xiaowei Yu
    Lei Zhang
    Medical Oncology, 2013, 30
  • [3] Down-regulation of ribosomal protein L22 in non-small cell lung cancer
    Yang, Mingxia
    Sun, Haibo
    Wang, Hong
    Zhang, Shijiang
    Yu, Xiaowei
    Zhang, Lei
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [4] Down-Regulation of Shisa3 Is Associated with Gefitinib Resistance in Non-Small Cell Lung Cancer
    Si, J.
    Yang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2380 - S2381
  • [5] Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer
    Yang, Junquan
    Liu, Hongxia
    Wang, Hongbin
    Sun, Yuman
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (08) : 490 - 494
  • [6] Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer
    Han, Chang Hoon
    Cho, Jae Yong
    Moon, Jong Tae
    Kim, Hyung Jung
    Kim, Se Kyu
    Shin, Dong Hwan
    Chang, Joon
    Ahn, Ckul Min
    Kim, Sung Kyu
    Chang, Yoon Soo
    ONCOLOGY REPORTS, 2006, 16 (06) : 1205 - 1210
  • [7] Down-regulation of microRNA-539 promotes tumor growth and invasion through regulating FSCN1 expression in non-small cell lung cancer
    Zou, Liyong
    Xu, Hong
    Xu, Wen
    Fu, Juan
    Qin, Yue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 11846 - 11855
  • [8] Clinical Significance of Expression of Cancer/testis Antigen and Down-regulation of HLA Class-I in Patients with Stage I Non-small Cell Lung Cancer
    Hanagiri, Takeshi
    Shigematsu, Yoshiki
    Shinohara, Shinji
    Takenaka, Masaru
    Oka, Sohich
    Chikaishi, Yasuhiro
    Nagata, Yoshika
    Baba, Tetsuro
    Uramoto, Hidetaka
    So, Tomoko
    Yamada, Sohsuke
    ANTICANCER RESEARCH, 2013, 33 (05) : 2123 - 2128
  • [9] MicroRNAs EXPRESSION PROFILES IN NON-SMALL CELL LUNG CANCER
    Yaroglu, Hatice Yildirim
    Akbayir, Serin
    Gorur, Aysegul
    Balci, Senay
    Unal, Nil
    Ayaz, Lokman
    Ayan, Erhan
    Tamer, Lulufer
    FRESENIUS ENVIRONMENTAL BULLETIN, 2021, 30 (7A): : 9107 - 9113
  • [10] Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer
    Morris, Scott
    Vachani, Anil
    Pass, Harvey I.
    Rom, William N.
    Ryden, Kirk
    Weiss, Glen J.
    Hogarth, D. K.
    Runger, George
    Richards, Donald
    Shelton, Troy
    Mallery, David W.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (11) : 2355 - 2362
12345